Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 40 resultados

INFRAPLUS: Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un HORIZON EUROPE: HORIZON-INFRA-2023-DEV-01 In response to the HORIZON-INFRA-2023-DEV-01-03 call, INFRAPLUS aims to expand INFRAFRONTIER's capacity for human disease modelling, refine...
2024-06-20 - 2027-05-31 | Financiado

ActSwiftly: Activation and switch of fates in T lymphocytes. USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE tramitó un HORIZON EUROPE: ERC-2023-COG Antigen-stimulated naïve CD8+ T cells proliferate and differentiate into effector and memory cells. Whereas effector T cells remove infected...
2024-03-14 - 2029-12-31 | Financiado

TREM2MEDS: Towards the clinical implementation of TREM2 Microglia Engineering for treating DementiaS USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un HORIZON EUROPE: HORIZON-EIC-2023-TRANSITION-01 TREM2MEDS emerges from the ERC PoC 2022 project TREM2μENGINES (Grant agreement ID: 101069395), which validated the efficacy of a novel treat...
2024-03-05 - 2027-03-31 | Financiado

ProgRet: European Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 ProgRET will create a multidisciplinary and intersectoral European training network focusing on the mechanisms, diagnosis and therapy of dom...
2023-07-05 - 2027-12-31 | Financiado

EOSC4Cancer: A European wide foundation to accelerate Data driven Cancer Research USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EOSC-01 Cancer complex nature requires integration of advanced research data across national boundaries to enable progress. Indeed, the Horizon Euro...
2022-06-09 - 2025-02-28 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

Algae4IBD: ALGAE4IBD FROM NATURE TO BEDSIDE ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMA... USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un H2020: H2020-FNR-2020 Algae4IBD's mission is to develop commercial products for Inflammatory Bowel Disease (IBD) prevention and treatment using aquatic natural bi...
2021-05-03 - 2025-05-31 | Financiado

ENHPATHY: Molecular basis of human enhanceropathies USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un H2020: H2020-MSCA-ITN-2019 Mutations within coding genes have traditionally been considered the major genetic cause of human disease. However, it is becoming increasin...
2019-08-09 - 2024-02-29 | Financiado

SILIA: Solid Immersion Lens Microscopy to Study Cilia Assembly USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE tramitó un H2020: H2020-MSCA-IF-2018 Cilia and flagella are evolutionary conserved organelles indispensable for vital processes in eukaryotic organisms, such as environment sens...
2019-03-20 - 2021-12-21 | Financiado

EU-OPENSCREEN-DRIVE: Ensuring long term sustainability of excellence in chemical biology within Europe and beyond USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un H2020: H2020-INFRADEV-2018-2020 EU-OPENSCREEN (EU-OS), the European Research Infrastructure of Open Screening Platforms for Chemical Biology, builds a distributed organizat...
2018-12-13 - 2023-10-31 | Financiado

EOSC-Life: Providing an open collaborative space for digital biology in Europe USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un H2020: H2020-INFRAEOSC-2018-2020 EOSC-Life brings together the 13 Biological and Medical ESFRI research infrastructures (BMS RIs) to create an open collaborative space for...
2018-11-20 - 2023-08-31 | Financiado

FunDiT: Functional Diversity of T cells USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE tramitó un H2020: ERC-2018-STG T cells have a central role in most adaptive immune responses, including immunity to infection, cancer, and autoimmunity. Increasing evidenc...
2018-10-10 - 2023-12-31 | Financiado

IMGENE: Improving Genome Editing Efficiency IMGENE USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE participó en un H2020: H2020-MSCA-ITN-2017 CRISPR genome editing technology is considered to become the greatest technological improvement in biomedical research since the invention o...
2017-07-18 - 2021-08-31 | Financiado

ARIB: Advanced Research Incubator in Biosciences ARIB A centre of excellence for disseminating quality... USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE tramitó un H2020: H2020-WIDESPREAD-2016-2017 Despite the influx of European regional development funds into the Czech Republic including the Central Bohemian Region (CBR), there is not...
2017-07-07 - 2018-08-31 | Financiado

LIGER: Identification of novel substrates for ubiquitin ligases involved in cell cycle and cell migration USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE tramitó un H2020: H2020-MSCA-IF-2016 Cancer cells heavily rely on the proteasome-ubiquitin system mediated tuning of proteins stability and proteome composition. Proteasome and...
2017-02-03 - 2019-10-09 | Financiado